Application 1068
Prostate specific antigen (PSA) near patient testing for diagnosis and management of prostate cancer
Application No. | 1068 |
| Application Name | Prostate specific antigen (PSA) near patient testing for diagnosis and management of prostate cancer |
| Advisory Panel | Professor Brendon Kearney (Chair and MSAC member) Professor Syd Bell (MSAC member) Dr Peter Swindle (Australian and New Zealand Association of Urological Surgeons nominee) Dr Justin Vivian (Australian and New Zealand Association of Urological Surgeons nominee) |
| Date Received by MSAC Secretariat | 20 November 2003 |
| Stage 1 - Eligibility | Eligible |
| Stage 2 - Assessment | Completed |
| Stage 3 - Formulation of Advice to the Minister | This assessment was considered by the MSAC at the 2 March 2005 meeting. The MSAC recommended that on the strength of evidence pertaining to safety, effectiveness and cost-effectiveness of prostate specific antigen testing for the diagnosis and management of prostate cancer, the current funding arrangements remain unchanged. |
| Stage 4 - Decision | Endorsed by the Minister for Health and Ageing 4 July 2005 |
| Stage 5 - Implementation |  |
Page currency, Latest update: 03 April, 2009
